Revolution Medicines RVMDW
NASDAQ RVMDW
$10.69 +0.51 (+5.01%)
At close: Nov 4, 2026 · 4:00 PM EST

Revolution Medicines (RVMDW) Preferred Stock Liabilities (2019)

Updated

Revolution Medicines' Preferred Stock Liabilities came in at $305.11 million for Q4 2019, unchanged from the prior quarter.

Analysis

Revolution Medicines (RVMDW) Preferred Stock Liabilities (2019) Analysis & Trends

Going back to Q1 2019, Revolution Medicines' Preferred Stock Liabilities data covers 4 quarters.

  • Going back by year, Preferred Stock Liabilities was $205.08 million in FY2018.
  • The five-year range for quarterly Preferred Stock Liabilities is $205.08 million (Q1 2019) to $305.11 million (Q3 2019).
  • Business Quant data shows RVMDW's Preferred Stock Liabilities at $305.11 million (Q3 2019), $295.02 million (Q2 2019) and $205.08 million (Q1 2019) in the three quarters before Q4 2019.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 305.11 Mn
Sep 30, 2019 305.11 Mn
Jun 30, 2019 295.02 Mn
Mar 31, 2019 205.08 Mn
API Access

Revolution Medicines Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=RVMDW&period=max&api_key=YOUR_API_KEY